{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T01:10:03Z","timestamp":1774660203639,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.jneuroim.2005.04.024","type":"journal-article","created":{"date-parts":[[2005,6,20]],"date-time":"2005-06-20T16:04:21Z","timestamp":1119283461000},"page":"172-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Proteasome antibodies in paraneoplastic cerebellar degeneration"],"prefix":"10.1016","volume":"165","author":[{"given":"Anette","family":"Storstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Vedeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2005.04.024_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0163-7258(03)00056-1","article-title":"Immune responses in cancer","volume":"99","author":"Adam","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib2","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/3315","article-title":"Tumor-specific killer cells in paraneoplastic cerebellar degeneration","volume":"4","author":"Albert","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.173.2.423","article-title":"Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus","volume":"173","author":"Arribas","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1042\/bj3460155","article-title":"Subcellular localization of proteasomes and their regulatory complexes in mammalian cells","volume":"346","author":"Brooks","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib5","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1073\/pnas.93.10.4529","article-title":"Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity and he brain","volume":"93","author":"Darnell","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ni0303-201","article-title":"Observing the invisible: successful tumor immunity in humans","volume":"4","author":"Darnell","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib8","first-page":"2136","article-title":"Cdr2, a target antigen of naturally occurring human tumor immunity, is widely expressed in gynecological tumors","volume":"60","author":"Darnell","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1084\/jem.184.4.1313","article-title":"Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus","volume":"184","author":"Feist","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1529-0131(199904)42:4<697::AID-ANR12>3.0.CO;2-H","article-title":"Autoantibodies in primary Sj\u00f6gren's syndrome are directed against proteasomal subunits of the alpha and beta type","volume":"42","author":"Feist","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000024427","article-title":"Diagnostic importance of anti-proteasome antibodies","volume":"123","author":"Feist","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0025-6196(12)62189-2","article-title":"Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume","volume":"65","author":"Hetzel","year":"1990","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib13","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/brain\/awf274","article-title":"The proteasome is a major autoantigen in multiple sclerosis","volume":"125","author":"Mayo","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2005.04.024_bib14","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1056\/NEJMp030092","article-title":"The proteasome\u2014an emerging therapeutic target in cancer","volume":"348","author":"Mitchell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.neuro.24.1.239","article-title":"Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration","volume":"24","author":"Musunuru","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib16","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1101\/gad.13.16.2087","article-title":"The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival","volume":"16","author":"Okano","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-5728(02)00439-3","article-title":"Interferon-gamma-inducible subunits are incorporated in human brain 20S proteasome","volume":"135","author":"Piccinini","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib18","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/sj.onc.1204854","article-title":"Role and fate of PML nuclear bodies in response to interferon and viral infections","volume":"20","author":"Regad","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jneuroim.2005.04.024_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1047-8477(02)00527-0","article-title":"Proteasome-dependent processing of nuclear proteins is correlated with their subnuclear localization","volume":"140","author":"Rockel","year":"2002","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1212\/WNL.42.2.361","article-title":"The expression of a cerebellar degeneration-associated neural antigen in human tumor line cells","volume":"42","author":"Sakai","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.04.024_bib21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with anitineuronal antibodies: analysis of 50 patients","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2005.04.024_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2004.05.014","article-title":"Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum","volume":"155","author":"Storstein","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/jaut.2000.0370","article-title":"Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519","volume":"14","author":"Vanderlugt","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s004010050460","article-title":"Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration","volume":"91","author":"Verschuuren","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0165-5728(97)00124-0","article-title":"Paraneoplastic anti-Hu serum: studies on human tumor cell lines","volume":"79","author":"Verschuuren","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib26","first-page":"6316","article-title":"The proteasome as a target for cancer therapy","volume":"9","author":"Voorhees","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2005.04.024_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1357-2725(02)00380-1","article-title":"Intracellular localization of proteasomes","volume":"35","author":"Wojcik","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280500175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280500175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:02:40Z","timestamp":1759046560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557280500175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S016557280500175X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.04.024","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteasome antibodies in paraneoplastic cerebellar degeneration","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}